Linenberger receives Presidential Award from American Society for Apheresis

This is the apheresis society's most prestigious annual award and is bestowed upon a member of the Society who has consistently made major contributions to, and performed outstanding service for the Society over a number of years.

Linenberger is a Professor of Hematology and holds the Robert & Phyllis Henigson Endowed Chair at the University of Washington. He is the Medical Director of Apheresis and Cellular Therapy at the Seattle Cancer Care Alliance (SCCA) and Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center.

He maintains a busy outpatient hematology practice at SCCA and he is the Program Director for the Hematology/Oncology fellowship at UW/Fred Hutch.

He is also the Medical Director of the Cellular Processing Facility (a GMP production laboratory) of the Fred Hutchinson Cancer Research Center, which provides critical support and technical expertise for the procurement, characterization and manufacturing of cell-based products for the treatment of patients with malignant and non-malignant diseases. These include investigational protocols and a research specimen repository. Dr. Linenberger is also deeply involved in teaching, training and career development through his faculty and Program Director roles.